行情

RELV

RELV

Reliv国际制药
OTCPK

实时行情|Nasdaq Last Sale

4.170
+0.270
+6.92%
已收盘, 16:00 05/13 EDT
开盘
--
昨收
3.970
最高
--
最低
--
成交量
--
成交额
--
52周最高
4.750
52周最低
1.510
市值
439.48万
市盈率(TTM)
-41.4925
分时
5日
1月
3月
1年
5年
Reliv International更新反向股票拆分交易
Reliv International (RELV) -2.7% AH, updated its plan to suspend its obligations to file periodic and current reports and other information with the SEC and to to delist its stock.Effective date for
Seekingalpha · 2020/12/04 21:28
Reliv reports Q3 results
Reliv (RELV): Q3 GAAP EPS of -$0.07.Revenue of $8.67M (-5.2% Y/Y)Press Release
Seekingalpha · 2020/11/13 12:21
Reliv' International Q3 EPS $(0.07) Up From $(0.09) YoY, Sales $8.70M Down From $9.15M YoY
Reliv' International (NASDAQ:RELV) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported $8.70 million in
Benzinga · 2020/11/13 12:10
Reliv International announces reverse stock split and delisting from Nasdaq
Followed immediately by a 2,000 for 1 forward stock split, Reliv International (RELV) will effect a 1 for 2,000 reverse stock split of its common stock on November 29, 2020.Stockholders
Seekingalpha · 2020/10/19 11:21
DDS, WIMI, SOL and FBIO among midday movers
Gainers: iHuman (IH) +44%.Dillard's (DDS) +37%.Acorn International (ATV) +36%.Wah Fu Education (WAFU) +29%.Lizhi (LIZI) +29%.Apex Global Brands (APEX) +25%.WiMi Hologram Cloud (WIMI) +25%.Surface Oncology (SURF) +19%.Skillful Craftsman Education Technology (EDTK) +16%.Reliv'
Seekingalpha · 2020/10/12 16:45
Reliv reports Q2 results
Reliv (RELV): Q2 GAAP EPS of -$0.11.Revenue of $8M (-3.1% Y/Y)Shares +2.9% PM.Press Release
Seekingalpha · 2020/08/14 11:18
Reliv' International Q2 EPS $(0.11) Up From $(0.22) YoY, Sales $8.00M Down From $8.26M YoY
Reliv' International (NASDAQ:RELV) reported quarterly losses of $(0.11) per share. This is a 50 percent increase over losses of $(0.22) per share from the same period last year. The company reported $8.00 million in
Benzinga · 2020/08/14 11:09
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 2020/05/29 09:35
更多
暂无数据
了解RELV最新的财务预测,通过RELV每股收益,每股净资产,每股现金流等数据分析Reliv国际制药近期的经营情况,然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
食品加工
+1.66%
食品和烟类
+1.76%
高管信息
Chairman/Director
Robert Montgomery
President/Chief Executive Officer
Ryan Montgomery
Vice Chairman/Chief Scientific Officer/Director
Carl Hastings
Chief Financial Officer/Senior Vice President
Steven Albright
Corporate Executive
R. Scott Montgomery
Corporate Executive
Thomas Pinnock
Chief Operating Officer/Senior Vice President
Debra Hellweg
Executive Vice President/Director of Sales/Director of Marketing
Steven Hastings
Senior Vice President/General Counsel/Secretary
Stephen Merrick
Senior Vice President/Director of Marketing
Kurt Wulff
Vice President
Jim Lahm
Independent Director
Robert Henry
Independent Director
John Klimek
Independent Director
Denis St. John
Independent Director
David Thibodeau
暂无数据
暂无数据
RELV 简况
Reliv'International, Inc.是一系列营养补充品的开发商、制造商和营销商,该公司的营养补充品专注于营养、特定保健需求、体重管理和运动营养。该公司通过一个独立的国际经销商网络营销体系销售其产品。该公司提供约20种营养补充品。该公司的营养补充品包括Reliv Classic与Reliv NOW、Innergize!、FibRestore和LunaRich X。Reliv Classic与Reliv NOW是含有维生素、矿物质、蛋白质和草药的两种基本营养补充品。Innergize!是一种具有两种口味的等渗运动营养补充品。FibRestore是一种高纤维与抗氧化的补充剂。LunaRich X是一种含有改善露那辛水平的大豆浓缩胶囊。该公司拥有约44,590家经销商,包括美国的32,270多家和国际市场的12,320多家。

微牛提供Reliv International, Inc(OTCPK-RELV)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的RELV股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易RELV股票基本功能。